✦ LIBER ✦

Recombinant single chain immunotoxins specific for the EGF receptor and ErbB-2

✍ Scribed by Mathias Schmidt; Nancy E. Hynes; Bernd Groner; Winfried Wels

Book ID: 116167822
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 133 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)99933-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gab1 is required for EGF receptor signal

Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2

✍ Yamasaki, Satoru; Nishida, Keigo; Yoshida, Yuichi; Itoh, Motoyuki; Hibi, Masahik 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 441 KB

Recombinant antibody toxins specific for

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e

Construction, Bacterial Expression and C

Construction, Bacterial Expression and Characterization of a Bifunctional Single–Chain Antibody–Phosphatase Fusion Protein Targeted to the Human ERBB–2 Receptor

✍ Wels, Winfried ;Harwerth, Ina-Maria ;Zwickl, Marcus ;Hardman, Norman ;Groner, Be 📂 Article 📅 1992 🏛 Nature Publishing Group 🌐 English ⚖ 927 KB

Diminution of antibodies directed agains

Diminution of antibodies directed against tumor cell surface epitopes: A single chain Fv fusion molecule specifically recognizes the extracellular domain of the c-erbB-2 receptor

✍ WELS, W; HARWERTH, I; HYNES, N; GRONER, B 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Phase I clinical study of the recombinan

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

✍ Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 326 KB

Correction: Phase I clinical study of th

Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

✍ Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 33 KB